1. Moving Prostate Cancer Care Forward: Putting Lessons From New Orleans and Chicago Into Practice

3. Program Goals

4. Prostate Cancer Overview

5. mCRPC Current Treatment Options

6. ALSYMPCA Trial Design

7. ALSYMPCA Efficacy and Safety Data

8. ALSYMPCA 3-Year Follow-up Safety Data

9. International EAP Safety Data

10. International EAP OS by Patient Baseline Characteristics

11. Ra-223 Completion of Therapy Variables

12. International EAP OS by Concomitant Medications

13. mCRPC Bone Markers and OS

14. mCRPC Ra Docetaxel

15. Novel AR Antagonist ARN-509

16. Novel AR Antagonist ODM-201

17. Moving CRPC Care Forward Take Home Points

18. Abbreviations

19. Abbreviations (cont)

20. References

21. References (cont)

22. References (cont)

23. References (cont)

24. References (cont)

25. References (cont)